2016 annual financial data

Voyager Therapeutics 2016 Net margin

Voyager Therapeutics 2016 net margin with verified reported values.

Direct answer

Net margin was -282.65%.

Operating income was -41,299,000 USD and net income was -40,193,000 USD.
Operating cash flow was -42,482,000 USD.

Get free Voyager Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
14,220,000 USD
Operating income
-41,299,000 USD
Net income
-40,193,000 USD
Operating cash flow
-42,482,000 USD